An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses

Psychoneuroendocrinology

Volumn 36, Issue 7, 2011, Pages 1010-1020

  Witt, Stephanie H ^a   Buchmann, Arlette F ^a   Blomeyer, Dorothea ^a   Nieratschker, Vanessa ^a   Treutlein, Jens ^a   Esser, Günter ^b   Schmidt, Martin H ^a   Bidlingmaier, Martin ^c   Wiedemann, Klaus ^d   Rietschel, Marcella ^a   Laucht, Manfred ^a,b   Wüst, Stefan ^a   Zimmermann, Ulrich S ^a,e  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Early adversity; GxE interaction; HPA; Neuropeptide Y; Stress

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NEUROPEPTIDE Y; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INDIVIDUALITY; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; MENTAL STRESS; NEUROENDOCRINE SYSTEM; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SOCIAL ISOLATION; SOCIAL STRESS; STRESS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENDOCRINE SYSTEM; GENE-ENVIRONMENT INTERACTION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; LIFE CHANGE EVENTS; LONGITUDINAL STUDIES; NEUROPEPTIDE Y; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, GENETIC; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 79960610704     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.12.015     Document Type: Article

References (75)

1. Amstadter A.B., Koenen K.C., Ruggiero K.J., Acierno R., Galea S., Kilpatrick D.G., Gelernter J. NPY moderates the relation between hurricane exposure and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 2010, 27(3):270-275.
2. Antonijevic I.A., Murck H., Bohlhalter S., Frieboes R.M., Holsboer F., Steiger A. Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 2000, 39(8):1474-1481.
3. Bellingrath S., Kudielka B.M. Effort-reward-imbalance and overcommitment are associated with hypothalamus-pituitary-adrenal (HPA) axis responses to acute psychosocial stress in healthy working schoolteachers. Psychoneuroendocrinology 2008, 33(10):1335-1343.
4. Belsky J., Jonassaint C., Pluess M., Stanton M., Brummett B., Williams R. Vulnerability genes or plasticity genes?. Mol. Psychiatry 2009, 14(8):746-754.
5. Benarroch E.E. Neuropeptide Y: its multiple effects in the CNS and potential clinical significance. Neurology 2009, 72(11):1016-1020.
6. Bjorntorp P., Rosmond R. The metabolic syndrome-a neuroendocrine disorder?. Br. J. Nutr. 2000, 83(Suppl. 1):S49-57.
7. Bogdan R., Pizzagalli D.A. The heritability of hedonic capacity and perceived stress: a twin study evaluation of candidate depressive phenotypes. Psychol. Med. 2009, 39(2):211-218.
8. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., Herman J.P. Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab. 2008, 19(5):175-180.
9. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav. Pharmacol. 1995, 6(3):215-222.
10. Buckland P.R., Hoogendoorn B., Coleman S.L., Guy C.A., Smith S.K., O'Donovan M.C. Strong bias in the location of functional promoter polymorphisms. Hum. Mutat. 2005, 26(3):214-223.
11. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 2010, 167(5):509-527.
12. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 2005, 57(10):1117-1127.
13. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301(5631):386-389.
14. Chapman D.P., Whitfield C.L., Felitti V.J., Dube S.R., Edwards V.J., Anda R.F. Adverse childhood experiences and the risk of depressive disorders in adulthood. J. Affect. Disord. 2004, 82(2):217-225.
15. Chrousos G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2009, 5(7):374-381.
16. Chrousos G.P., Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci. STKE 2005, 2005(304):pe48.
17. Dallman M.F., Pecoraro N., Akana S.F., La Fleur S.E., Gomez F., Houshyar H., Bell M.E., Bhatnagar S., Laugero K.D., Manalo S. Chronic stress and obesity: a new view of "comfort food" Proc. Natl. Acad. Sci. U.S.A. 2003, 100(20):11696-11701.
18. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6(6):463-475.
19. Derijk R.H. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 2009, 16(5):340-352.
20. Dimitrov E.L., DeJoseph M.R., Brownfield M.S., Urban J.H. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity. Endocrinology 2007, 148(8):3666-3673.
21. Eaton K., Sallee F.R., Sah R. Relevance of neuropeptide Y (NPY) in psychiatry. Curr. Top. Med. Chem. 2007, 7(17):1645-1659.
22. Edwards V.J., Holden G.W., Felitti V.J., Anda R.F. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am. J. Psychiatry 2003, 160(8):1453-1460.
23. Federenko I.S., Nagamine M., Hellhammer D.H., Wadhwa P.D., Wüst S. The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J. Clin. Endocrinol. Metab. 2004, 89(12):6244-6250.
24. Federenko I.S., Schlotz W., Kirschbaum C., Bartels M., Hellhammer D.H., Wüst S. The heritability of perceived stress. Psychol. Med. 2006, 36(3):375-385.
25. Gray W.P. Neuropeptide Y signalling on hippocampal stem cells in health and disease. Mol. Cell. Endocrinol. 2008, 288(1-2):52-62.
26. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38(4):213-224.
27. Heilig M., Koob G.F., Ekman R., Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 1994, 17(2):80-85.
28. Heilig M., Soderpalm B., Engel J.A., Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl.) 1989, 98(4):524-529.
29. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33(6):693-710.
30. Held K., Antonijevic I., Murck H., Kuenzel H., Steiger A. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology 2006, 31(1):100-107.
31. Hellhammer D.H., Wüst S., Kudielka B.M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 2009, 34(2):163-171.
32. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 2001, 62(1-2):77-91.
33. Ising M., Depping A.M., Siebertz A., Lucae S., Unschuld P.G., Kloiber S., Horstmann S., Uhr M., Muller-Myhsok B., Holsboer F. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur. J. Neurosci. 2008, 28(2):389-398.
34. Itokawa M., Arai M., Kato S., Ogata Y., Furukawa A., Haga S., Ujike H., Sora I., Ikeda K., Yoshikawa T. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci. Lett. 2003, 347(3):202-204.
35. Jimenez-Vasquez P.A., Diaz-Cabiale Z., Caberlotto L., Bellido I., Overstreet D., Fuxe K., Mathe A.A. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders sensitive line rat model of depression. Eur. Neuropsychopharmacol. 2007, 17(4):298-308.
36. Karl T., Chesworth R., Duffy L., Herzog H. Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y(1) receptor. Neuropeptides 2010, 44(3 (June)):233-239.
37. Kirschbaum C., Pirke K.M., Hellhammer D.H. The "trier social stress test" -a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28(1-2):76-81.
38. Kudielka B.M., Hellhammer D.H., Wüst S. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology 2009, 34(1):2-18.
39. Kudielka B.M., Wüst S., Kirschbaum C., Hellhammer D.H. Trier Social Stress Test. Encyclopedia of Stress 2007, 776-781. Academic Press, Oxford. Second ed. G. Fink (Ed.).
40. Kumsta R., Entringer S., Koper J.W., van Rossum E.F., Hellhammer D.H., Wust S. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol. Psychiatry 2007, 62(8):863-869.
41. Kuo L.E., Czarnecka M., Kitlinska J.B., Tilan J.U., Kvetnansky R., Zukowska Z. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Ann. NY Acad. Sci. 2008, 1148:232-237.
42. Kupper N., de Geus E.J., van den Berg M., Kirschbaum C., Boomsma D.I., Willemsen G. Familial influences on basal salivary cortisol in an adult population. Psychoneuroendocrinology 2005, 30(9):857-868.
43. Ladd C.O., Huot R.L., Thrivikraman K.V., Nemeroff C.B., Meaney M.J., Plotsky P.M. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog. Brain Res. 2000, 122:81-103.
44. Larhammar D., Salaneck E. Molecular evolution of NPY receptor subtypes. Neuropeptides 2004, 38(4):141-151.
45. Laucht M., Esser G., Baving L., Gerhold M., Hoesch I., Ihle W., Steigleider P., Stock B., Stoehr R.M., Weindrich D., Schmidt M.H. Behavioral sequelae of perinatal insults and early family adversity at 8 years of age. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39(10):1229-1237.
46. Laucht M., Esser G., Schmidt M.H. Developmental outcome of infants born with biological and psychosocial risks. J. Child Psychol. Psychiatry 1997, 38(7):843-853.
47. Lindell S.G., Schwandt M.L., Sun H., Sparenborg J.D., Bjork K., Kasckow J.W., Sommer W.H., Goldman D., Higley J.D., Suomi S.J., Heilig M., Barr C.S. Functional NPY variation as a factor in stress resilience and alcohol consumption in rhesus macaques. Arch. Gen. Psychiatry 2010, 67(4):423-431.
48. McEwen B.S., Gianaros P.J. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann. NY Acad. Sci. 2010, 1186:190-222.
49. Morales-Medina J.C., Dumont Y., Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Res. 2010, 1314:194-205.
50. Morgan C.A., Rasmusson A.M., Wang S., Hoyt G., Hauger R.L., Hazlett G. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol. Psychiatry 2002, 52(2):136-142.
51. Müller R., Abbet J.P. Changing trends in the consumption of legal and illegal drugs by 11-16-year old adolescent pupils. Findings from a study conducted under the auspices of the World Health Organisation (WHO Europe). Problems 1991, Swiss Professional Service for Alcohol, Lausanne.
52. Nikisch G., Agren H., Eap C.B., Czernik A., Baumann P., Mathe A.A. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. Int. J. Neuropsychopharmacol. 2005, 8(3):403-410.
53. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008, 31(9):464-468.
54. Parker A.J., Wessely S., Cleare A.J. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol. Med. 2001, 31(8):1331-1345.
55. Paschos K.A., Veletza S., Chatzaki E. Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression. CNS Drugs 2009, 23(9):755-772.
56. Redrobe J.P., Dumont Y., Quirion R. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci. 2002, 71(25):2921-2937.
57. Risch N., Herrell R., Lehner T., Liang K.Y., Eaves L., Hoh J., Griem A., Kovacs M., Ott J., Merikangas K.R. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301(23):2462-2471.
58. Rutter, M., Quinton, D., 1977. McGurk, H. (Ed.), Psychiatric disorder - ecological factors and concepts of causation. Ecological factors in human development. Amsterdam, North Holland, pp. 173-187.
59. Sajdyk T.J., Shekhar A., Gehlert D.R. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 2004, 38(4):225-234.
60. Sanchez M.M., Ladd C.O., Plotsky P.M. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev. Psychopathol. 2001, 13(3):419-449.
61. Schmidt M.V., Liebl C., Sterlemann V., Ganea K., Hartmann J., Harbich D., Alam S., Muller M.B. Neuropeptide Y mediates the initial hypothalamic-pituitary-adrenal response to maternal separation in the neonatal mouse. J. Endocrinol. 2008, 197(2):421-427.
62. Shah S.H., Freedman N.J., Zhang L., Crosslin D.R., Stone D.H., Haynes C., Johnson J., Nelson S., Wang L., Connelly J.J., Muehlbauer M., Ginsburg G.S., Crossman D.C., Jones C.J., Vance J., Sketch M.H., Granger C.B., Newgard C.B., Gregory S.G., Goldschmidt-Clermont P.J., Kraus W.E., Hauser E.R. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet. 2009, 5(1):e1000318.
63. Sommer W.H., Lidstrom J., Sun H., Passer D., Eskay R., Parker S.C., Witt S.H., Zimmermann U.S., Nieratschker V., Rietschel M., Margulies E.H., Palkovits M., Laucht M., Heilig M. Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect. Hum. Mutat. 2010, 31(8):E1594-E1608.
64. Thorsell A. Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake. Ann. NY Acad. Sci. 2008, 1148::136-140.
65. Thorsell A., Carlsson K., Ekman R., Heilig M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 1999, 10(14):3003-3007.
66. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathe A.A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(23):12852-12857.
67. Thorsell A., Svensson P., Wiklund L., Sommer W., Ekman R., Heilig M. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul. Pept. 1998, 75-76:247-254.
68. Uher R., McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol. Psychiatry 2010, 15(1):18-22.
69. Wittchen H.U., Zaundig M., Fydrich T. Structured Clinical Interview for SDM-IV Axis I and II - SCID] 1997, Hogrefe, Göttingen.
70. Wüst S., Federenko I., Hellhammer D.H., Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25(7):707-720.
71. Wüst S., Kumsta R., Treutlein J., Frank J., Entringer S., Schulze T.G., Rietschel M. Sex-specific association between the 5-HTT gene-linked polymorphic region and basal cortisol secretion. Psychoneuroendocrinology 2009, 34(7):972-982.
72. Wüst S., Van Rossum E.F., Federenko I.S., Koper J.W., Kumsta R., Hellhammer D.H. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab. 2004, 89(2):565-573.
73. Yehuda R. Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder. Ann. NY Acad. Sci. 1997, 821:57-75.
74. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452(7190):997-1001.
75. Zimmermann U., Spring K., Kunz-Ebrecht S.R., Uhr M., Wittchen H.U., Holsboer F. Effect of ethanol on hypothalamic-pituitary-adrenal system response to psychosocial stress in sons of alcohol-dependent fathers. Neuropsychopharmacology 2004, 29(6):1156-1165.